Table 2.
Characteristics∗ median (IQR), or N (column %) | Overall (n = 1645) | VCY, log10 copy-years | P | %PY with viral load >200 copies/mL | P | %PY with viral load > 50 copies/mL | P† |
All participants | 1645 (100.0) | 3.0 (2.3–4.2) | 9.7 (0.9–46.7) | 25.5 (6.0–72.0) | |||
Age, y | <.001 | <.001 | <.001 | ||||
<35 | 630 (38.3) | 3.0 (2.2–4.3) | 12.4 (0.8–58.8) | 29.0 (7.2–80.1) | |||
35–45 | 557 (33.9) | 3.2 (2.4–4.4) | 12.2 (1.8–45.8) | 27.7 (8.4–76.8) | |||
>45 | 458 (27.8) | 2.7 (2.1–3.7) | 6.1 (0.0–28.7) | 19.1 (3.8–52.2) | |||
Sex | .019 | <.001 | <.001 | ||||
Male | 1289 (78.4) | 3.0 (2.2–4.1) | 8.0 (0.6–41.3) | 23.6 (5.5–67.7) | |||
Female | 356 (21.6) | 3.1 (2.4–4.5) | 18.0 (2.4–63.1) | 35.9 (9.1–86.7) | |||
Race/ethnicity | <.001 | <.001 | <.001 | ||||
Non-Hispanic/Latino white | 743 (45.2) | 3.0 (2.2–4.1) | 6.2 (0.7–30.6) | 20.1 (4.4–58.0) | |||
Non-Hispanic/Latino black | 606 (36.8) | 3.1 (2.4–4.5) | 18.0 (2.3–66.4) | 35.9 (12.6–86.8) | |||
Hispanic/Latino ethnicity | 224 (13.6) | 2.9 (2.2–4.2) | 9.0 (0.3–41.8) | 24.1 (4.7–66.4) | |||
Other race/ethnicity | 72 (4.4) | 2.5 (2.1–3.5) | 5.3 (0.0–21.1) | 17.4 (3.6–40.9) | |||
HIV risk activity | <.001 | <.001 | <.001 | ||||
MSM | 929 (56.5) | 2.9 (2.2–4.0) | 6.0 (0.5–30.7) | 19.1 (4.4–56.0) | |||
PWID | 90 (5.5) | 3.1 (2.4–4.6) | 23.9 (3.7–74.1) | 46.7 (15.8–92.2) | |||
Heterosexual | 525 (31.9) | 3.1 (2.4–4.4) | 19.3 (2.9–64.4) | 36.3 (12.4–85.6) | |||
Unknown/other risk | 101 (6.1) | 3.3 (2.3–4.5) | 12.1 (0.0–57.5) | 26.8 (4.2–82.5) | |||
Payer | .42 | <.001 | <.001 | ||||
Private | 882 (53.6) | 2.9 (2.2–4.1) | 6.5 (0.5–33.0) | 20.2 (4.5–60.1) | |||
Public | 506 (30.8) | 3.0 (2.2–4.4) | 18.6 (1.5–62.4) | 35.4 (10.8–86.1) | |||
None/unknown/other | 257 (15.6) | 3.1 (2.4–4.1) | 12.5 (2.0–48.4) | 28.6 (10.3–75.0) | |||
Died | <.001 | <.001 | <.001 | ||||
Yes | 115 (7.0) | 3.7 (2.7–4.9) | 44.1 (11.8–91.6) | 81.9 (26.2–100.0) | |||
No | 1530 (93.0) | 2.9 (2.2–4.2) | 8.5 (0.6–41.9) | 23.8 (5.5–66.7) |
%PY = percent person-years, IQR = interquartile range, MSM = men who have sex with men, PWID = persons who inject drugs, VCY = viremia copy-years.
Characteristics are summarized at baseline (defined as the date 6 months after cART initiation), unless otherwise indicated.
Wilcoxon rank-sum tests for continuous variables, Yates-corrected chi-square test for categorical variables.